Skip to content

Organon logo

Main menu
  • Etkilerimiz
    • Hakkımızda
    • Kültürümüz
      • Vizyon, misyon ve değerler
      • Çeşitlilik, eşitlik ve kapsayıcılık
    • Liderlerimiz
      • Liderlerimiz
      • Yönetim Ekibi
      • Yönetim Kurulu
    • Çevre, Toplum & Denetim
    • İlkelerimiz
    • Tedarikçiler
  • Medya
    • Medya
    • Basın bültenleri
  • Yatırımcı ilişkileri
    • Yatırımcı ilişkilerine genel bakış
    • SEC dosyalaması
  • Ekibimize katılın

Contact Us

Products list

Change language

Worldwide

Back
Change Language
  • Bizimle İletişime Geçin
  • Global locations
Main menu
Organon site directory
  • The Americas
    • Organon
      Brazil
      Canada  English  ·  French
      Latin America
      Mexico
      USA
  • Europe
    • Organon
      Austria
      Belgium  Dutch  ·  English  ·  French
      Czech Republic
      Denmark
      Finland
      France
      Germany
      Ireland
      Italy
      Luxembourg  English  ·  French
      Netherlands  Dutch  ·  English
      Norway
      Portugal
      Russia
      Spain
      Sweden
      Switzerland
      United Kingdom
  • Asia Pacific
    • Organon
      Australia
      Hong Kong, China
      Indonesia
      Japan
      Malaysia
      New Zealand
      Philippines
      Singapore
      South Korea
      Taiwan
      Thailand
      Vietnam
  • Middle East & Africa
    • Organon
      Middle East  English  ·  Arabic
      Northwest Africa  French  ·  Arabic  ·  Turkey
      South Africa
View all locations and contact information
What can we help you find?
Search for:

Yönetim Kurulu

Organon Yönetim Kurulu, ilaç sektöründe çeşitliliğe sahip yönetim kurullarından biridir. Yöneticilerimiz, şirketin vizyonuna ulaşma yolunda bize özgün bakış açılarını katmaktadır.

Photo of Carrie Cox

Carrie Cox
Photo of Kevin Ali

Kevin Ali
Photo of Robert Essner

Robert Essner
Photo of Alan Ezekowitz

Alan Ezekowitz
Photo of Ma Fatima de Vera Francisco

Ma Fatima de Vera Francisco
Photo of Helene Gayle

Helene Gayle
Photo of Shelly Lazarus

Shelly Lazarus
Photo of Deborah “Debbie” Leone

Deborah “Debbie” Leone
Photo of Martha McGarry

Martha McGarry
Photo of Philip Ozuah

Philip Ozuah
Photo of Cynthia Patton

Cynthia Patton
Photo of Grace Puma

Grace Puma
Photo of Shalini Sharp

Shalini Sharp
Organon logo

Şirket

  • Hakkımızda
  • Liderlerimiz
  • Çevre, Toplum & Denetim

Kaynaklar

  • Hasta kaynakları
  • Yatırımcı ilişkileri
  • Medya

Bizimle iletişime geçin

  • Bizimle iletişime geçin
  • İletişim bilgisi
  • Global locations
  • İleriye Dönük Açıklama
  • Çerez politikası
  • Gizlilik Politikası
  • KULLANIM ŞARTLARI
  • Site haritası
Telif hakkı © Organon şirketler grubuna aittir. Tüm hakları saklıdır.

You are leaving Organon.com

Cancel Continue

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept